Jane Grogan - 01 Nov 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Research
Signature
/s/ Wendell Taylor, attorney-in-fact for Dr. Grogan
Issuer symbol
BIIB
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
4
Filing time
03 Nov 2023, 17:06:35 UTC
Previous filing
12 Oct 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 0 01 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +2,085 $0.000000 2,085 01 Nov 2023 Common Stock 2,085 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of November 1, 2023.